文献速递妇科

在卵巢癌女性中实施通用基因检测质量改进项目

Implementation of a quality improvement project for universal genetic testing in women with ovarian cancer.
PubMed 文献 · Gynecol Oncol · 2018-04-10

该质量改进项目在学术妇科肿瘤实践中,通过提供者培训、患者教育、电子健康记录文档强化和预约安排优化,回顾性确定2008年1月至2013年11月基线转诊率后,前瞻性收集2013年12月1日至2016年11月30日新诊断卵巢癌患者数据。实施后基因检测完成率从27%升至82%(P≤0.001),转诊率、遗传咨询和检测完成率均显著改善。

要点

  • 实施后基因检测完成率82%,较实施前27%显著提高(P≤0.001)。
  • 低成本的提供者与患者教育、电子健康记录利用和预约流程简化可显著提高检测完成率。
  • 项目在可访问电子健康记录的学术妇科肿瘤实践中实施。

核心结论

  • 针对提供者和患者关于基因检测重要性的教育、利用电子健康记录以及简化患者预约服务的低成本干预可显著提高基因检测完成率。

研究设计与样本

  • 回顾性审查2008年1月至2013年11月诊断为卵巢癌的患者以确定基线转诊率,随后实施结合提供者培训、患者教育、强化电子健康记录文档和改善预约安排策略的过程改变模型,并前瞻性收集2013年12月1日至2016年11月30日期间新诊断且未进行基因检测的卵巢癌患者数据。

主要发现

  • 实施前基因检测率为27%,实施后为82%(P≤0.001)。
  • 遗传转诊率、遗传咨询和检测完成率均显著改善。

临床怎么用

  • 作者认为,针对提供者和患者关于基因检测重要性的教育、利用电子健康记录以及简化患者预约服务的低成本干预可显著提高基因检测完成率。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The National Comprehensive Cancer Network recommends all women with ovarian cancer be offered genetic testing. Despite a decade of endorsement, many oncology practitioners have yet to make this a part of routine practice. Referral to genetic counseling and completion of genetic testing among patients at substantial risk of germline mutations are significantly lacking, adversely affecting patient care and squandering an opportunity to maximize cancer prevention efforts. This project determined the impact and feasibility of implementing a basic model for universal referral to genetic counseling and completion of genetic testing in women with a diagnosis of ovarian cancer in an academic gynecology oncology practice with access to electronic health records (EHRs). METHODS: Patients diagnosed with ovarian cancer from January 2008 to November 2013 were retrospectively reviewed to determine the baseline referral rate for genetic counseling and testing completion in our practice. Implementation of a process change model combining provider training, patient education, enhanced electronic health record documentation and improved patient appointment scheduling strategies were implemented. We then prospectively collected data on all newly diagnosed ovarian cancer patients that had not already undergone genetic testing presenting from December 1, 2013 to November 30, 2016. RESULTS: Genetic referral rates, genetic counseling and testing completion rates were markedly improved. Pre-implementation our genetic testing rate was 27% and post implementation our testing rate was 82% (p-value≤0.001). CONCLUSIONS: Low cost interventions that target education of both providers and patients regarding the importance of genetic testing along with utilization of the EHR and streamlined patient appointment services can significantly increase rates of genetic testing completion.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Uyar D, Neary J, Monroe A, et al. Implementation of a quality improvement project for universal genetic testing in women with ovarian cancer. Gynecol Oncol. 2018. PMID: 29653687. doi:10.1016/j.ygyno.2018.03.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。